About MEDILABO US, INC
Medilabo RFP is a biopharmaceutical company pioneering nasal drug delivery for neurodegenerative diseases, focusing on direct brain access via the olfactory nerve. Their technology enables the delivery of drugs to the brain while bypassing first-pass metabolism and reducing systemic side effects.
Nasal drug delivery technology targeting the olfactory zone for direct brain accessOptimized formulation to deliver over 50% of the dose to the olfactory regionRepurposing of failed compounds for CNS treatment using intranasal deliveryDevelopment of nasal formulations for neurodegenerative diseases including Alzheimer’s, Parkinson’s, and depression
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to MEDILABO US, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.